DBVE-PC regimen

	WikiDoc Resources for DBVE-PC regimen
Articles
Most recent articles on DBVE-PC regimen Most cited articles on DBVE-PC regimen Review articles on DBVE-PC regimen Articles on DBVE-PC regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on DBVE-PC regimen Images of DBVE-PC regimen Photos of DBVE-PC regimen Podcasts & MP3s on DBVE-PC regimen Videos on DBVE-PC regimen
Evidence Based Medicine
Cochrane Collaboration on DBVE-PC regimen Bandolier on DBVE-PC regimen TRIP on DBVE-PC regimen
Clinical Trials
Ongoing Trials on DBVE-PC regimen at Clinical Trials.gov Trial results on DBVE-PC regimen Clinical Trials on DBVE-PC regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on DBVE-PC regimen NICE Guidance on DBVE-PC regimen NHS PRODIGY Guidance FDA on DBVE-PC regimen CDC on DBVE-PC regimen
Books
Books on DBVE-PC regimen
News
DBVE-PC regimen in the news Be alerted to news on DBVE-PC regimen News trends on DBVE-PC regimen
Commentary
Blogs on DBVE-PC regimen
Definitions
Definitions of DBVE-PC regimen
Patient Resources / Community
Patient resources on DBVE-PC regimen Discussion groups on DBVE-PC regimen Patient Handouts on DBVE-PC regimen Directions to Hospitals Treating DBVE-PC regimen Risk calculators and risk factors for DBVE-PC regimen
Healthcare Provider Resources
Symptoms of DBVE-PC regimen Causes & Risk Factors for DBVE-PC regimen Diagnostic studies for DBVE-PC regimen Treatment of DBVE-PC regimen
Continuing Medical Education (CME)
CME Programs on DBVE-PC regimen
International
DBVE-PC regimen en Espanol DBVE-PC regimen en Francais
Business
DBVE-PC regimen in the Marketplace Patents on DBVE-PC regimen
Experimental / Informatics
List of terms related to DBVE-PC regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: ABVE-PC Regimen; Adriamycin-Bleomycin-Vincristine-Etoposide/Prednisone-Cyclophosphamide Regimen; DBVE-PC; POG 9245 Regimen

Overview

DBVE-PC regimen refers to a regimen consisting of doxorubicin, bleomycin, vincristine, etoposide, prednisone and cyclophosphamide, given in combination with radiation therapy and used for the treatment of high-risk, childhood Hodgkin's lymphoma.^[1]^[2]

Regimen

C – Cyclophosphamide

Indications

References

↑ "NCI Thesaurus".
↑ "R-CHOP - National Cancer Institute".
↑ Coiffier, Bertrand (2002-01-24). "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma". The New England Journal of Medicine. 346 (4): 235–242. doi:10.1056/NEJMoa011795. ISSN 1533-4406. PMID 11807147. Unknown parameter |coauthors= ignored (help)
↑ Kluin-Nelemans, H. C. (2012-08-09). "Treatment of older patients with mantle-cell lymphoma". The New England Journal of Medicine. 367 (6): 520–531. doi:10.1056/NEJMoa1200920. ISSN 1533-4406. PMID 22873532. Unknown parameter |coauthors= ignored (help)

[1] "NCI Thesaurus".

[2] "R-CHOP - National Cancer Institute".

[3] Coiffier, Bertrand (2002-01-24). "CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma". The New England Journal of Medicine. 346 (4): 235–242. doi:10.1056/NEJMoa011795. ISSN 1533-4406. PMID 11807147. Unknown parameter |coauthors= ignored (help)

[4] Kluin-Nelemans, H. C. (2012-08-09). "Treatment of older patients with mantle-cell lymphoma". The New England Journal of Medicine. 367 (6): 520–531. doi:10.1056/NEJMoa1200920. ISSN 1533-4406. PMID 22873532. Unknown parameter |coauthors= ignored (help)

[1]

[2]

[3]

[4]

DBVE-PC regimen

Overview

Regimen

Indications

References

Navigation menu